Yamamoto M, Fujii S, Hatanaka Y
Department of Neurology, Kagawa Prefectural Central Hospital, Bancho, Takamatsu, Japan.
Clin Neuropharmacol. 1997 Aug;20(4):371-3. doi: 10.1097/00002826-199708000-00010.
Results of long-term administration of L-threo-3,4-dihydroxyphenylserine (L-DOPS), a synthetic precursor of noradrenaline, in a patient with freezing gait and pure akinesia are reported. Effects were temporal and disappeared during a 16-month treatment period. It was recognized that pure akinesia is an early symptom of progressive supranuclear palsy (PSP). Previously, we reported results of short-term (4 weeks) administration of L-DOPS in this patient. We present the further clinical course of the patient, along with results of long-term (16 months) administration of L-DOPS.
本文报告了一名患有冻结步态和单纯运动不能的患者长期服用去甲肾上腺素的合成前体L-苏式-3,4-二羟基苯丝氨酸(L-DOPS)的结果。其效果是暂时的,在16个月的治疗期内消失。现已认识到单纯运动不能是进行性核上性麻痹(PSP)的早期症状。此前,我们报告了该患者短期(4周)服用L-DOPS的结果。我们展示了该患者的进一步临床病程,以及长期(16个月)服用L-DOPS的结果。